Financials

  • Market Capitalization 1.82 B
  • Employee 167
  • Founded 2019
  • CEO N/A
  • Website www.zenasbio.com
  • Headquarter Delaware, United States
  • FIGI BBG01J1MG9D6
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-2.15
Fiyat/satışlar oranı

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
2055
PGEN
Precigen, Inc. - Common Stock
5.12 USD-0.97%-5.19%+6.44%+175.27%1.83 B USD
2058
ANAB
AnaptysBio, Inc. - Common Stock
62.51 USD-10.46%-6.55%+4.18%+77.59%1.82 B USD
2060
STOK
Stoke Therapeutics, Inc. - Common Stock
29.13 USD-1.12%-11.32%-3.96%+146.24%1.81 B USD
2071
ZYME
Zymeworks Inc. - Common Stock
24.66 USD-1.12%-7.36%+5.84%+39.01%1.80 B USD